The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer

Oncogene

Volumn 36, Issue 39, 2017, Pages 5544-5550

  Szczepny, A ^a   Rogers, S ^b,c   Jayasekara, W S N ^a   Park, K ^d   McCloy, R A ^b   Cochrane, C R ^a,e   Ganju, V ^a,e,f   Cooper, W A ^g   Sage, J ^h   Peacock, C D ⁱ   Cain, J E ^a   Burgess, A ^b,c   Watkins, D N ^b,c,j  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF VIRGINIA   (United States)

^e MONASH UNIVERSITY   (Australia)

^f SOUTHERN HEALTH   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h STANFORD CANCER INSTITUTE   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j ST VINCENT S HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; PROTEIN P53; SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; FIBROBLAST; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; HEDGEHOG SIGNALING; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; TUMOR GROWTH; UPREGULATION; ANIMAL; C57BL MOUSE; DISEASE COURSE; DISEASE MODEL; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEDGEHOG PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA;

EID: 85030479909     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2017.173     Document Type: Article

References (40)

1. Briscoe J, Thérond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol 2013; 14: 418-431.
2. Pak E, Segal RA. Hedgehog signal transduction: key players, oncogenic drivers, and cancer therapy. Dev Cell 2016; 38: 333-344.
3. Marini KD, Payne BJ, Watkins DN, Martelotto LG. Mechanisms of Hedgehog signalling in cancer. Growth Factors 2011; 29: 221-234.
4. Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med 2013; 19: 1410-1422.
5. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422: 313-317.
6. Park K-S, Martelotto LG, Peifer M, Sos ML, Karnezis AN, Mahjoub MR et al. A crucial requirement for Hedgehog signaling in small cell lung cancer. Nat Med 2011; 17: 1504-1508.
7. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003; 4: 181-189.
8. Lewis PM, Dunn MP, McMahon JA, Logan M, Martin JF, St-Jacques B et al. Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 2001; 105: 599-612.
9. Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010; 138: 1810-1822.
10. DuPage M, Dooley AL, Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protocol 2009; 4: 1064-1072.
11. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71.
12. Wong SY, Seol AD, So P-L, Ermilov AN, Bichakjian CK, Epstein EH et al. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009; 15: 1055-1061.
13. Youssef KK, Van Keymeulen A, Lapouge G, Beck B, Michaux C, Achouri Y et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol 2010; 12: 299-305.
14. Ericson J, Morton S, Kawakami A, Roelink H, Jessell TM. Two critical periods of sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 1996; 87: 661-673.
15. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR, Speicher MR. Defining 'chromosomal instability'. Trends Genet 2008; 24: 64-69.
16. Heng HH, Bremer SW, Stevens JB, Horne SD, Liu G, Abdallah BY et al. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution. Cancer Metastasis Rev 2013; 32: 325-340.
17. Pfau SJ, Amon A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep 2012; 13: 515-527.
18. Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A et al. Kinaseindependent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget 2015; 6: 8525-8538.
19. Fombonne J, Bissey P-A, Guix C, Sadoul R, Thibert C, Mehlen P. Patched dependence receptor triggers apoptosis through ubiquitination of caspase-9. Proc Natl Acad Sci U S A 2012; 109: 10510-10515.
20. Adolphe C, Hetherington R, Ellis T, Wainwright B. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 2006; 66: 2081-2088.
21. Barnes EA, Kong M, Ollendorff V, Donoghue DJ. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J 2001; 20: 2214-2223.
22. de Cárcer G, Malumbres M. A centrosomal route for cancer genome instability. Nat Cell Biol 2014; 16: 504-506.
23. Nam H-J, van Deursen JM. Cyclin B2 and p53 control proper timing of centrosome separation. Nat Cell Biol 2014; 16: 538-549.
24. Badea TC, Wang Y, Nathans J. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci 2003; 23: 2314-2322.
25. Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 2014; 25: 735-747.
26. Gazdar AF, Savage TK, Johnson JE, Berns A, Sage J, Linnoila RI et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J Thorac Oncol 2015; 10: 553-564.
27. Gazdar AF, Hirsch FR, Minna JD. From mice to men and back: an assessment of preclinical model systems for the study of lung cancers. J Thorac Oncol 2016; 11: 287-299.
28. Cui M, Augert A, Rongione M, Conkrite K, Parazzoli S, Nikitin AY et al. PTEN is a potent suppressor of small cell lung cancer. Mol Cancer Res 2014; 12: 654-659.
29. McFadden D, Papagiannakopoulos T, Taylor-Weiner A, Stewart C, Carter SL, Cibulskis K et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 2014; 156: 1298-1311.
30. Wu N, Jia D, Ibrahim AH, Bachurski CJ, Gronostajski RM, MacPherson D. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer. Oncotarget 2016; 7: 57514-57524.
31. Shaukat Z, Liu D, Choo A, Hussain R, O'Keefe L, Richards R et al. Chromosomal instability causes sensitivity to metabolic stress. Oncogene 2015; 34: 4044-4055.
32. Stevens JB, Horne SD, Abdallah BY, Ye CJ, Heng HH. Chromosomal instability and transcriptome dynamics in cancer. Cancer Metastasis Rev 2013; 32: 391-402.
33. Sheltzer JM. A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. Cancer Res 2013; 73: 6401-6412.
34. O'Toole SA, Machalek DA, Shearer RF, Millar EK, Millar EKA, Nair R et al. Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res 2011; 71: 4002-4014.
35. Roos G, Landberg G, Huff JP, Houghten R, Takasaki Y, Tan EM. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies. Lab Invest 1993; 68: 204-210.
36. Detre S, Saclani Jotti G, Dowsett MA. 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995; 48: 876-878.
37. Nagy A, Gertsenstein M, Vintersten K, Behringer R. Karyotyping mouse cells. CSH Protoc 2008; pdb.prot4706; doi:10.1101/pdb.prot4706
38. McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, Burgess A. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle 2014; 13: 1400-1412.
39. Rogers S, Fey D, McCloy RA, Parker BL, Mitchell NJ, Payne RJ et al. PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells. J Cell Sci 2016; 129: 1340-1354.
40. Robles-Oteiza C, Taylor S, Yates T, Cicchini M, Lauderback B, Cashman CR et al. Recombinase-based conditional and reversible gene regulation via XTR alleles. Nat Commun 2015; 6: 8783.